Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B

SIMPLE SUMMARY: Concomitant hepatic steatosis is common in patients with chronic hepatitis B (CHB), but data regarding its impact on the natural history of CHB remain sparse and conflicting. Recently, metabolic-associated fatty liver disease (MAFLD) was defined as hepatic steatosis in the presence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ming-Whei, Lin, Chih-Lin, Liu, Chun-Jen, Wu, Wan-Jung, Hu, Jui-Ting, Huang, Yi-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736898/
https://www.ncbi.nlm.nih.gov/pubmed/36497492
http://dx.doi.org/10.3390/cancers14236012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736898/
https://www.ncbi.nlm.nih.gov/pubmed/36497492
http://dx.doi.org/10.3390/cancers14236012

Ejemplares similares